Publications by authors named "Deborah Kupferwasser"

Background: Before SARS-CoV-2 vaccination availability, medical center employees were at high risk of COVID-19. However, risk factors for SARS-CoV-2 infection in medical center employees, both healthcare and non-healthcare workers, are poorly understood.

Methods: From September-December 2020, free IgG antibody testing was offered to all employees at a large urban medical center.

View Article and Find Full Text PDF

Objective: To investigate whether empiric carbapenem therapy, compared to empiric non-carbapenem therapy, was associated with improved clinical outcomes among hospitalized, non-intensive care unit (ICU) patients with extended-spectrum β-lactamase (ESBL)-producing Enterobacterales infections.

Methods: We performed a retrospective cohort study of adult, non-ICU patients admitted with ESBL-producing Enterobacterales infections. Primary outcome was time to clinical stability from the first empiric antibiotic dose.

View Article and Find Full Text PDF

Skin and Soft Tissue Infections (SSTIs) are common bacterial infections. We hypothesized that due to the COVID-19 pandemic, SSTI rates would significantly decrease due to directives to avoid unneeded care and attenuated SSTIs risk behaviours. We retrospectively examined all patients with an ICD-10 diagnosis code in the Los Angeles County Department of Health Services, the second largest U.

View Article and Find Full Text PDF

Introduction: SARS-CoV-2 is the etiologic agent of coronavirus disease 2019 (COVID-19). Questions remain regarding correlates of risk and immune protection against COVID-19.

Methods: We prospectively enrolled 200 participants with a high risk of SARS-CoV-2 occupational exposure at a U.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated vaccine hesitancy among essential workers, highlighting how factors like perceived susceptibility, perceived threat, and self-efficacy are linked to reluctance to receive the COVID-19 vaccine.
  • A survey was conducted with 1,327 essential workers at a Los Angeles medical center, revealing that 22% were hesitant about getting vaccinated, particularly among women and racial/ethnic minorities.
  • Results showed that prior flu vaccination behavior and job type influenced hesitancy, with a notable difference between healthcare roles, but the expected psychological factors were not linked to vaccine attitudes, suggesting other unassessed influences may play a role.
View Article and Find Full Text PDF

Staphylococcus aureus is the leading cause of skin and skin structure infections (SSSI) in humans. Moreover, the high frequency of recurring SSSI due to S. aureus, particularly methicillin-resistant S.

View Article and Find Full Text PDF

Increasing rates of life-threatening infections and decreasing susceptibility to antibiotics urge development of an effective vaccine targeting Staphylococcus aureus. This study evaluated the efficacy and immunologic mechanisms of a vaccine containing a recombinant glycoprotein antigen (NDV-3) in mouse skin and skin structure infection (SSSI) due to methicillin-resistant S. aureus (MRSA).

View Article and Find Full Text PDF
Article Synopsis
  • - The structure-mechanism relationships of host defense peptides significantly affect their antimicrobial effectiveness, influenced by anatomical, physiological, and microbiological factors.
  • - The synthetic peptide RP-1 showed varying degrees of efficacy against different pathogens (Salmonella, Staphylococcus, and Candida) depending on pH, being more effective against bacteria at pH 7.5 and against Candida at pH 5.5.
  • - Molecular analyses revealed that RP-1's action is context-dependent, with differential effects on target organisms influenced by pH and lipid environments, suggesting strategies for developing effective antimicrobial peptides with reduced toxicity.
View Article and Find Full Text PDF

Recent discoveries suggest cysteine-stabilized toxins and antimicrobial peptides have structure-activity parallels derived by common ancestry. Here, human antimicrobial peptide hBD-2 and rattlesnake venom-toxin crotamine were compared in phylogeny, 3D structure, target cell specificity, and mechanisms of action. Results indicate a striking degree of structural and phylogenetic congruence.

View Article and Find Full Text PDF
Article Synopsis
  • - Platelets (PLTs) play a role in fighting infections by releasing microbicidal proteins (PMPs) and kinocidins (PKs) against Staphylococcus aureus, particularly when PLT-to-bacteria ratios exceed 10:1, showing significant effectiveness against both susceptible and resistant strains.
  • - Inhibitors targeting various PLT receptors, like P2X and P2Y, reduce the release of PMPs and PKs, compromising PLT's antimicrobial activity, but other pathways related to thromboxane A(2) and cyclooxygenase's function do not affect the anti-staph responses.
  • - The mechanism behind PLT's anti-S. aureus action includes a critical
View Article and Find Full Text PDF

Mammalian platelets contain an array of antimicrobial peptides, termed platelet microbicidal proteins (PMPs). Human and rabbit PMPs include known chemokines, such as platelet factor-4 (hPF-4); PMP-1 is the rabbit orthologue of hPF-4. Chemokines that also exert direct antimicrobial activity have been termed kinocidins.

View Article and Find Full Text PDF

Chemokines are small (8-12 kDa) effector proteins that potentiate leukocyte chemonavigation. Beyond this role, certain chemokines have direct antimicrobial activity against human pathogenic organisms; such molecules are termed kinocidins. The current investigation was designed to explore the structure-activity basis for direct microbicidal activity of kinocidins.

View Article and Find Full Text PDF

Aspirin has been previously shown to reduce the in vivo virulence of Staphylococcus aureus in experimental endocarditis, through antiplatelet and antimicrobial mechanisms. In the present study, salicylic acid, the major in vivo metabolite of aspirin, mitigated two important virulence phenotypes in both clinical and laboratory S. aureus strains: alpha-hemolysin secretion and fibronectin binding in vitro.

View Article and Find Full Text PDF

Ribosomal S6 kinase 2 (S6K2) is a serine/threonine kinase identified as a homologue of p70 ribosomal S6 kinase 1 (S6K1). S6K1 and S6K2 show different cellular localization as well as divergent amino acid sequences in non-catalytic domains, suggesting that their cellular functions and/or regulation may not be identical. Many of the serine/threonine residues that become phosphorylated and contribute to S6K1 activation are conserved in S6K2.

View Article and Find Full Text PDF